New drug trial offers hope for Tough-to-Treat blood cancer
NCT ID NCT06539195
Summary
This study is testing an experimental drug called DZD8586 for adults with an aggressive type of blood cancer (DLBCL) that has come back or stopped responding to previous treatments. The main goal is to see if the drug can shrink tumors and how well patients tolerate it. Researchers will also measure how much of the drug stays in the body and track any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B CELL LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
National Clinical Research Center for Blood Diseases, Blood Disease Hospital & Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College
Tianjin, Tianjin Municipality, 300020, China
-
Research Site
Hefei, Anhui, 230031, China
-
Research Site
Beijing, Beijing Municipality, 100083, China
-
Research Site
Guangzhou, Guangdong, 510060, China
-
Research Site
Nanning, Guangxi, 530016, China
-
Research Site
Zhengzhou, Henan, 450003, China
-
Research Site
Wuhan, Hubei, 430023, China
-
Research Site
Changsha, Hunan, 410031, China
-
Research Site
Jinan, Shandong, 250117, China
-
Research Site
Linyi, Shandong, 276002, China
-
Research Site
Xi’an, Shanxi, 710061, China
-
Research Site
Chengdu, Sichuan, 610041, China
-
Research Site
Tianjin, Tianjin Municipality, 300181, China
-
Research Site
Hangzhou, Zhejiang, 310009, China
Conditions
Explore the condition pages connected to this study.